Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

Infusions reduce lead levels but show no effect on clinical endpoints

News | Cardiovascular Clinical Studies

Chelation Therapy Does Not Improve Outcomes after Heart Attack

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

April 08, 2024

$Study suggests routine use is likely unnecessary for those with normal ejection fraction$

News | Cardiovascular Clinical Studies

Beta Blockers May Not Benefit Many Heart Attack Survivors

April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second ...

April 08, 2024

Mechanical circulatory support boosts survival in cardiogenic shock patients, despite risks

News | Cardiovascular Clinical Studies

Heart Pump Improves Survival After Severe Heart Attacks

April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly ...

April 08, 2024

Ticagrelor alone outperforms 12-month DAPT for reducing bleeding with no increased risk

News | Cardiovascular Clinical Studies

Study Suggests Most Patients with Acute Coronary Syndromes Can Safely Stop Aspirin One Month After Percutaneous Coronary Intervention

April 8, 2024 — People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin ...

April 08, 2024

Earning points or small sums of money encourages people to ‘step up’ their physical activity

News | Cardiovascular Clinical Studies

Incentives Prompt Increased Daily Walking in Patients at Risk for Heart Disease

April 7, 2024 — Strategies such as earning points or small amounts of money encouraged people at high risk for heart ...

April 07, 2024

When added to standard blood pressure medication, new drug could minimize the need for pills and reduce cardiovascular risks

News | Cardiovascular Clinical Studies

One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg

April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing ...

April 07, 2024

Results show drug is effective and safe, leaves open question of optimal dosing

News | Cardiovascular Clinical Studies

Study Finds Olezarsen Cuts Triglyceride Levels by About Half

April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated ...

April 07, 2024

90% of high-risk patients on lerodalcibep achieved guideline-recommended cholesterol targets

News | Cardiovascular Clinical Studies

Novel PCSK9 Inhibitor Cut LDL Cholesterol Levels by More Than Half

April 7, 2024 — Among patients at high or very high risk for a heart attack or stroke, the addition of the ...

April 07, 2024

Novel drug shows promise for treating severe hypertriglyceridemia in patients at high risk for pancreatitis

News | Cardiovascular Clinical Studies

Plozasiran Reduces Triglyceride Levels by 74% at 24 Weeks

April 7, 2024 — In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the ...

April 07, 2024

$Study shows no benefit for heart failure overall but suggests different effects in those with preserved versus reduced ejection fraction$

News | Cardiovascular Clinical Studies

RELIEVE-HF Trial Outcomes Reported at ACC.24 Find Impact of Interatrial Shunt May Vary by Heart Failure Type

April 6, 2024 — Patients with heart failure who had a small shunt inserted between the heart’s left and right atria did ...

April 06, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack

News | Cardiovascular Clinical Studies

EMPACT-MI Trial Outcomes Reported at ACC.24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

April 6, 2024 — Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did ...

April 06, 2024

Exploratory analysis finds beneficial effect on patient outcomes at one year, according to a study presented at ACC.24.

News | Cardiovascular Clinical Studies

Research Presented at ACC 2024 Found No Reduction in 90-Day Deaths, Heart Attacks With Human Apo/A1

April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the ...

April 06, 2024

The Minneapolis Heart Institute Foundation (MHIF) is presenting data on trends in ST-elevation myocardial infarction (STEMI) at the American College of Cardiology’s Annual Scientific Session (ACC.24). An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovascular disease.

News | ACC

Research Data from Minneapolis Heart Institute Foundation at ACC 2024 Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks

April 6, 2024 — The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends ...

April 06, 2024

Smidt Heart Institute experts will be available for media interviews throughout ACC.24.

News | Artificial Intelligence

ACC.24: Smidt Heart Institute Experts to Share Research Findings, Clinical Knowledge

April 6, 2024 — Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more ...

April 06, 2024

Registration is open for a leading conference on structural heart disease announced by the Cardiovascular Research Foundation, CRF.

News | Cardiovascular Business

Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

April 05, 2024